ghk-cu hair growth clinical trial human GHK Peptide (2016) — Research Summary ghk-cu hair growth human clinical

No: HR-POK-007)

This result matters because statins remain one of the most refused medications in clinical practice

Why this trial matters : First effective gene therapy for EB Meaningfully improves quality of life and patient outcomes Drug Approvals as a Signal: 2025 Showed Real Late-Stage Productivity The FDAs 2025 novel drug approvals, alongside pivotal trialdriven cancer approvals, point to real late-stage productivity rather than incremental gains

On the injectable side: using plain sterile water instead of bacteriostatic water (your vial will grow bacteria within days), shaking the vial during reconstitution, injecting into the same spot every time, and going intramuscular when subcutaneous is the correct depth